Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment

Published:2024-05-08 Issue:3 Volume:52 Page:787-800
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Zhang Guan-Xuan-Zi,Liu Ting-Ting,Ren Ai-Xia,Liang Wen-Xin,Yin Hong,Cai Yun

Funder

National Natural Science Foundation of China

Cultivation Project of PLA General Hospital for Distinguished Young Scientists

New Medicine Clinical Research Fund

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s15010-024-02287-w.pdf

Reference49 articles.

1. Koulenti D, Xu E, Song A, et al. Emerging treatment options for infections by multidrug-resistant gram-positive microorganisms. Microorganisms. 2020. https://doi.org/10.3390/microorganisms8020191.

2. Jiang J, Hou Y, Duan M, et al. Design, synthesis and antibacterial evaluation of novel oxazolidinone derivatives nitrogen-containing fused heterocyclic moiety. Bioorg Med Chem Lett. 2021;32:127660. https://doi.org/10.1016/j.bmcl.2020.127660.

3. Rabon AD, Fisher JP, MacVane SH. Incidence and risk factors for development of thrombocytopenia in patients treated with linezolid for 7 days or greater. Ann Pharmacother. 2018;52:1162–4. https://doi.org/10.1177/1060028018783498.

4. Lan SH, Lin WT, Chang SP, et al. Tedizolid versus linezolid for the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis. Antibiotics. 2019. https://doi.org/10.3390/antibiotics8030137.

5. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agent Chemother. 1998;42:3251–5. https://doi.org/10.1128/aac.42.12.3251.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3